Abstract
The search for new antifungal agents was essential because of opportunistic infections in immunocompromised individuals and the development of resistance to currently used agents. Bryophytes offer a rich source of rare and structurally unique molecules and can serve as a reserve of potentially antifungal compounds for further development as pharmaceuticals. This minireview covered the chemical and biological research of Chinese bryophytes recently finished in our laboratory. Totally about 120 compounds have been isolated and identified from 17 bryophyte species collected from North to South of China. The antifungal effect of these isolated compounds and their reversal of resistance of Candida albicans to fluconazole were evaluated. The possible reversal mechanisms were also preliminarily tested.
Current Organic Chemistry
Title: Chemical Constituents from the Chinese Bryophytes and Their Reversal of Fungal Resistance
Volume: 12 Issue: 8
Author(s): Chunfeng Xie and Hongxiang Lou
Affiliation:
Abstract: The search for new antifungal agents was essential because of opportunistic infections in immunocompromised individuals and the development of resistance to currently used agents. Bryophytes offer a rich source of rare and structurally unique molecules and can serve as a reserve of potentially antifungal compounds for further development as pharmaceuticals. This minireview covered the chemical and biological research of Chinese bryophytes recently finished in our laboratory. Totally about 120 compounds have been isolated and identified from 17 bryophyte species collected from North to South of China. The antifungal effect of these isolated compounds and their reversal of resistance of Candida albicans to fluconazole were evaluated. The possible reversal mechanisms were also preliminarily tested.
Export Options
About this article
Cite this article as:
Xie Chunfeng and Lou Hongxiang, Chemical Constituents from the Chinese Bryophytes and Their Reversal of Fungal Resistance, Current Organic Chemistry 2008; 12 (8) . https://dx.doi.org/10.2174/138527208784577385
DOI https://dx.doi.org/10.2174/138527208784577385 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot topic: Psychotropic Drugs in Child and Adolescent Psychiatry - a New Era on the Horizon (Executive Editors: Aribert Rothenberger, Manfred Gerlach and Ralf W. Dittmann)]
Current Pharmaceutical Design The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain
Current Neuropharmacology Solid-State Structure of Abeta (Aβ) in Alzheimer's Disease
Protein & Peptide Letters Disturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Current Alzheimer Research Astrocytes: Targets for Neuroprotection in Stroke
Central Nervous System Agents in Medicinal Chemistry Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimers Disease
Current Pharmaceutical Design Effect of Lithium on Neurocognitive Functioning
Current Alzheimer Research Activin and TGF-β Effects on Brain Development and Neural Stem Cells
CNS & Neurological Disorders - Drug Targets Cachexia and Oxidative Stress in Cancer: An Innovative Therapeutic Management
Current Pharmaceutical Design Subject Index to Volume 5
Current Genomics Nuezhenide Exerts Anti-Inflammatory Activity through the NF-κB Pathway
Current Molecular Pharmacology Urinary Steroid Measurements in Some Endocrine and Psychiatric Diseases
Current Medicinal Chemistry Commentary (Research Highlights)
CNS & Neurological Disorders - Drug Targets Current Therapy and Computational Drug Designing Approaches for Neurodegenerative Diseases -with Focus on Alzheimer’s and Parkinson’s.
Current Signal Transduction Therapy The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimers Disease
Current Pharmaceutical Design Pathological Gambling in Parkinson’s Disease: An Update on Medical Management
Current Psychopharmacology Commentary-1 (Research Highlights: USP30 Regulates the Mitophagy-Mediated Neuroprotection in Parkinson’s Disease)
CNS & Neurological Disorders - Drug Targets CREG: A Possible Candidate for Both Prevention and Treatment of Proliferative Vascular Disease
Current Molecular Medicine Rikkunshito and Ghrelin Secretion
Current Pharmaceutical Design Synthesis and Structure-Activity Studies of Peptide-Acridine/Acridone Conjugates
Current Medicinal Chemistry